Detoxification of genotoxic compounds as a threshold mechanism limiting their carcinogenicity.
In vitro metabolic trends were assessed for 100 genotoxic agents detected in two bacterial test systems, i.e., the Ames reversion test and a liquid DNA-repair test in Escherichia coli. Seventy-five compounds were found to undergo a more or less pronounced decrease of genotoxicity, in at least one of these models, in the presence of rat liver homogenates or in other metabolic systems (up to 40 different preparations, from various sources, for chromium compounds). A number of these deactivable compounds are reported in the literature to yield negative or equivocal results in animal carcinogenicity assays, which may imply the existence of metabolically regulated thresholds in the initiation of cancer. Several examples are provided to support this hypothesis. The in vitro treatment with a pharmacologic agent (N-acetylcysteine) enhanced detoxification mechanisms, either by stimulating enzyme activities promoting glutathione formation in liver homogenates or by reacting itself with direct-acting mutagens and with the genotoxic metabolites of procarcinogens.
D016604:Aflatoxin B1; D000348:Aflatoxins / Q000378:metabolism / Q000633:toxicity; D000818:Animals; D001711:Biotransformation; D002273:Carcinogens / Q000378:metabolism*; D004260:DNA Repair / Q000187:drug effects; D005978:Glutathione / Q000378:metabolism; D066298:In Vitro Techniques; D008658:Inactivation, Metabolic; D008099:Liver / Q000378:metabolism; D009152:Mutagenicity Tests; D009153:Mutagens / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000139:chemically induced; D011078:Polychlorinated Biphenyls / Q000378:metabolism / Q000633:toxicity; D051381:Rats; D012486:Salmonella typhimurium / Q000235:genetics
D000348:Aflatoxins; D002273:Carcinogens; D009153:Mutagens; D016604:Aflatoxin B1; D011078:Polychlorinated Biphenyls; D005978:Glutathione